Connect with us

Hi, what are you looking for?

Brilliant AchievementBrilliant Achievement

Editor's Pick

Pharmaceutical Pricing Around the World

Peter Van Doren

Medicine Pharmacy

The Committee on Health, Education, Labor, and Pensions, chaired by Senator Bernie Sanders (I‑VT), held a hearing on Tuesday in which he asked the CEO of Novo Nordisk why its diabetes and weight loss drugs, Ozempic and Wegovy, cost much less in Europe than in the United States. Senator Sanders reflected popular sentiment when he said, “Treat the American people the same way that you treat people all over the world. Stop ripping us off.”

Why do drug prices vary across countries? An article in the Fall issue of Regulation offers some insight from economists.

The knowledge embodied in pharmaceuticals is a global public good. The incentives are for all countries to avoid the fixed costs of drug development and clinical trials and pay only the marginal costs of producing a drug. The demand for health care increases with income and population, so the worst-case possibility is that the richest and largest country—the US—pays all the fixed costs of drug development, and all other countries free ride and pay only the marginal costs.

The authors gathered data on sales revenue and compared the revenue to estimates of marginal cost to calculate each country’s contribution to the fixed costs of drug development. They conclude that a country’s GDP explains 83 percent of the variation in contributions across countries and the effect of income is greater than proportional. A country with a 100 percent higher GDP contributes 129 percent more to pharmaceutical R&D. 

So, the U.S. does contribute disproportionately to drug development costs. The rest of the world’s contribution is not zero but is less than would be predicted by income and population alone.

The authors conclude: “Our findings indicate prospective gains from international cooperation—from formal or informal international agreements among high-income countries. If other wealthy countries agreed to contribute more to the global public good, they, and the world, would benefit.”

Join The Exclusive Subscription Today And Get Premium Articles For Free
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

You May Also Like

Editor's Pick

Gene Healy I have no end of uncharitable thoughts about recent American presidents; yet, when I’m cataloging their sins, the words “undue caution” have...

Editor's Pick

Travis Fisher It’s no secret that administrative agencies have significantly overstepped their statutory authority in recent decades. The Supreme Court’s recent Loper Bright ruling—marking...

Editor's Pick

Walter Olson Here’s a roundup of election law and policy items I wish there were time to do as single posts: Confirming the intuitive:...

Editor's Pick

Walter Olson With apologies to Shakespeare, nothing in his term became him like the leaving it. Even those of us who regularly disagree with...